explore -WSS

explore

author：leisure time 2025-09-09 05:35:28 - browse：577

Susan Galbraith of AstraZeneca gestures while speaking – pharma coverage from STAT — Susan Galbraith, AstraZeneca’s head of cancer research and development, speaks at a STAT event in 2023. Marie Miller for STAT

CHICAGO — AstraZeneca’s head of cancer research and development, Susan Galbraith, is British, and prone to a particularly British style of understatement. She doesn’t boast loudly. But she did come to this year’s annual meeting of the American Society of Clinical Oncology wearing a small lapel pin with the numeral 6 and the “AZ” corporate logo.

That pin represents the number of years in a row that the London-based drug giant has had a presentation in the ASCO plenary, the conference’s biggest showcase for new data. This year, the company has two.

Scientific credibility is great, of course. But AstraZeneca’s shareholders want something else: return on investment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Albert Bourla of Pfizer: worst biopharma CEO of 2023

WSS

First recipient of genetically engineered pig kidney has died

Drinking less cuts risk of oral cavity, esophageal cancer: Report

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Elevance, private equity launch primary care company

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

entertainment

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Virginia high school admissions case could be legal follow

Readout LOUD podcast: What to know about H5N1 bird flu

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

After affirmative action ruling, medical educators look to 'holistic review'

Use wet bulb globe temperature, not heat index, to protect workers

How one medical school became remarkably diverse

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Medicare proposal to cover medical devices draws a mixed reaction

hotspot

Researchers on aging grapple with how to calculate biological age

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Hospitals owned by private equity see complications spike 25%

Medicare Advantage beneficiaries sue Humana over algorithm use

H5N1 communication has been strictly for the birds

focus

entertainment

hotspot

explore